8-K: Ultralife Q3 Revenue Up 21.5%, Operating Loss Amid Restructuring

Ultralife Corporation reported a 21.5% revenue increase to $43.4 million in Q3 2025, but posted an operating loss of $1.0 million due to one-time costs and operational inefficiencies.

Summary

• Total revenue increased 21.5% to $43.4 million for Q3 2025, compared to $35.7 million in Q3 2024.
• Excluding the Electrochem acquisition, organic sales grew 2.5% to $36.6 million.
• The company reported an operating loss of $1.0 million, a decline from an operating income of $0.5 million in Q3 2024, primarily due to $1.1 million in one-time non-recurring costs.
• GAAP EPS was ($0.07) for Q3 2025, down from $0.02 in Q3 2024.
• Adjusted EBITDA increased to $2.0 million (4.7% of sales) from $1.9 million (5.4% of sales) in the prior year.
• Backlog grew to $90.1 million at the end of Q3 2025, up from $84.5 million at the end of Q2 2025.
• Ultralife decided to close its Calgary battery pack assembly facility, incurring a $0.5 million charge, with expected annual savings of $0.8 million after completion in Q1 2026.

Sentiment

Score: 4

Explanation: While revenue growth and backlog are positive, the operating loss, decline in GAAP EPS, reduced gross margins, and impact of one-time costs and ongoing operational challenges (supply chain, delayed orders) indicate a challenging quarter. The planned facility closure and efficiency initiatives are forward-looking but reflect current issues.

Positives

• Total revenue increased by 21.5% to $43.4 million in Q3 2025, driven by the Electrochem acquisition.
• Organic sales, excluding Electrochem, grew by 2.5% to $36.6 million.
• Government/defense sales within Battery & Energy Products increased by 19.0% due to strong demand from a U.S.-based global prime.
• Communications Systems sales increased by 8.2% to $3.4 million.
• Adjusted EBITDA increased to $2.0 million from $1.9 million in the prior year quarter.
• Backlog increased to $90.1 million at the end of Q3 2025 from $84.5 million at the end of Q2 2025, indicating future revenue potential.
• The planned closure of the Calgary facility is expected to generate annual savings of approximately $0.8 million starting in Q1 2026.

Negatives

• The company reported an operating loss of $1.0 million in Q3 2025, compared to an operating income of $0.5 million in Q3 2024.
• GAAP EPS declined to ($0.07) per share from $0.02 per share in the prior year quarter.
• Gross profit margin decreased to 22.2% of revenue from 24.3% in Q3 2024.
• Battery & Energy Products gross margin decreased to 22.1% from 24.7% due to manufacturing inefficiencies from raw material quality issues and less favorable sales mix.
• Operating expenses increased significantly to $10.6 million from $8.2 million, partly due to $1.1 million in one-time non-recurring costs.
• Commercial sales within Battery & Energy Products decreased by 5.7%, primarily in oil & gas and medical sectors.
• Supply chain issues caused manufacturing inefficiencies in the Battery & Energy Products business.
• Orders continued to be delayed in the Communications Systems business, impacting overall profitability.
• Other expense increased to $0.8 million from $0.2 million, mainly due to interest expense from the Electrochem acquisition financing.

Risks

• Uncertain global economic conditions, including the impact of tariffs and inflation.
• Potential reductions in revenues from key customers.
• Delays or reductions in U.S. and foreign military spending.
• Challenges in global acceptance of new products.
• Disruptions, delays, or material price increases in the supply of raw materials and components due to business conditions, new or additional tariffs, global conflicts, weather, or other uncontrollable factors.

Future Outlook

The company is focused on converting long-term new product development into revenue, advancing vertical integration in the oil & gas segment, and maintaining a strong focus on operational efficiency initiatives to deliver sustainable profitable growth. Management expects to optimize operating leverage as new products advance into qualification and production, capitalizing on an expanding pipeline of large, multi-year programs. The closure of the Calgary facility is anticipated to yield approximately $0.8 million in annual savings starting in Q1 2026.

Management Comments

• "Although revenue grew 2.5% organically and 21.5% including the Electrochem acquisition for the third quarter, supply chain issues caused manufacturing inefficiencies in our Battery & Energy Products business and orders continued to be delayed in our Communications Systems business, both of which impacted overall profitability." Mike Manna, President and CEO.
• "In response, we are intensifying our lean and process improvement initiatives, improving supply chain resiliency and rationalizing our manufacturing operations." Mike Manna, President and CEO.
• "These actions are critical to ensuring we are best prepared to optimize the operating leverage of our business model as we advance several new products into qualification and production, and capitalize on an expanding pipeline of opportunities consisting primarily of large, multi-year programs." Mike Manna, President and CEO.
• "Our priorities remain converting long-term new product development efforts into revenue, advancing vertical integration in the oil & gas segment, and maintaining a strong focus on operational efficiency initiatives to deliver sustainable profitable growth and maximizing the value of our global brand." Mike Manna, President and CEO.

Industry Context

Ultralife operates in the power solutions and communications/electronics systems markets, serving government/defense and commercial customers globally. The increase in government/defense sales reflects strong demand from a U.S.-based global prime, indicating robust activity in that sector. However, declines in commercial sales, particularly in oil & gas and medical, suggest potential headwinds or competitive pressures in those specific commercial segments. The focus on vertical integration in oil & gas indicates a strategic effort to improve positioning in a challenging market. Supply chain issues and delayed orders are common challenges across many manufacturing industries, highlighting broader economic and logistical pressures.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results to assess Ultralife's performance against global benchmarks. Therefore, a direct comparison to industry standards based solely on this filing is not possible.

Legal Proceedings

• Litigation expenses were incurred for the company's cyber insurance claim, contributing to one-time non-recurring costs.

Stakeholder Impact

• Shareholders: Negative impact due to operating loss and reduced GAAP EPS, but potential for future savings from restructuring and growth from backlog and new products.
• Employees: Employees at the Calgary facility will be affected by the closure, with severance and termination costs incurred.
• Customers: Potential impact from supply chain issues and delayed orders in Communications Systems, but strong demand from government/defense customers.
• Creditors: Interest expense from Electrochem acquisition financing impacts profitability.

Next Steps

• Complete the closure of the Calgary battery pack assembly facility in the first quarter of 2026.
• Intensify lean and process improvement initiatives.
• Improve supply chain resiliency.
• Rationalize manufacturing operations.
• Advance new products into qualification and production.
• Convert long-term new product development efforts into revenue.
• Advance vertical integration in the oil & gas segment.
• Maintain a strong focus on operational efficiency initiatives.

Key Dates

Recommendation

The company reported an operating loss and negative GAAP EPS, which are significant concerns. While revenue growth (largely acquisition-driven) and an increased backlog are positive, they are overshadowed by declining gross margins, one-time restructuring costs, and ongoing operational challenges like supply chain issues and delayed orders. Management is taking corrective actions, such as facility rationalization and efficiency initiatives, which could yield future benefits. However, the immediate financial performance is weak. An investor would likely hold to see if the announced operational improvements and cost savings materialize and if the company can convert its backlog into profitable revenue, especially given the current headwinds.

Keywords

Ultralife Corporation, ULBI, Q3 2025 Earnings, Financial Results, Battery & Energy Products, Communications Systems, Electrochem Acquisition, Operating Loss, GAAP EPS, Adjusted EBITDA, Backlog, Calgary Facility Closure, Supply Chain Issues, Government Defense, Commercial Sales, Operational Efficiency, Manufacturing, SEC Filing, 8-K